Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

L3HARRIS TECHNOLOGIES, INC. /DE/ Director's Dealing 2023

Apr 5, 2023

29993_dirs_2023-04-05_59147fe3-60bf-4351-abf3-59532e13de5a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX)
CIK: 0000202058
Period of Report: 2023-04-03

Reporting Person: Rakita Melanie (Vice President & CHRO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, Par Value $1.00 737 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (Right to Buy) $197.73 2030-02-28 Common Stock, Par Value $1.00 (1813) Direct
Non-Qualified Stock Option (Right to Buy) $181.91 2031-02-26 Common Stock, Par Value $1.00 (1631) Direct
Non-Qualified Stock Option (Right to Buy) $233.51 2032-02-25 Common Stock, Par Value $1.00 (1273) Direct
Non-Qualified Stock Option (Right to Buy) $210.15 2033-02-24 Common Stock, Par Value $1.00 (1300) Direct
Restricted Stock Units $0.00 Common Stock, Par Value $1.00 (1787) Direct
Restricted Stock Units $0.00 Common Stock, Par Value $1.00 (378) Direct
Restricted Stock Units $0.00 Common Stock, Par Value $1.00 (3000) Direct
Restricted Stock Units $0.00 Common Stock, Par Value $1.00 (295) Direct
Restricted Stock Units $0.00 Common Stock, Par Value $1.00 (340) Direct

Footnotes

F1: Options to purchase shares of Issuer's common stock, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.

F2: Options to purchase shares of Issuer's common stock, 543 of which became exercisable on 2/26/2022, 544 of which became exercisable on 2/26/2023 and 544 of which become exercisable on 2/26/2024, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.

F3: Options to purchase shares of Issuer's common stock, 424 of which became exercisable on 2/25/2023, 424 of which become exercisable on 2/25/2024 and 425 of which become exercisable on 2/25/2025, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.

F4: Options to purchase shares of Issuer's common stock, 433 of which become exercisable on 2/24/2024, 433 of which become exercisable on 2/24/2025 and 433 of which become exercisable on 2/24/2026, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.

F5: Award of restricted stock units, which vest subject to continued employment (with certain exceptions) and the terms and conditions of the restricted unit award agreement. Each restricted stock unit represents a contingent right to receive 1 share of common stock, with vested units settled in shares common stock.

F6: Award of restricted stock units, of which one-half vests on 2/1/2025 and one-half vests on 2/1/2026, subject to continued employment (with certain exceptions) and the terms and conditions of the restricted unit award agreement. Each restricted stock unit represents a contingent right to 1 share of Issuer's common stock, with vested units settled in shares of Issuer's common stock.